191919-02-5 Usage
Uses
Used in Pharmaceutical Industry:
(Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid is used as a potential therapeutic agent for various medical applications due to its unique chemical structure and potential biological activity. Its ability to interact with metabolic processes or cell signaling pathways makes it a promising candidate for the development of new drugs targeting specific diseases.
Used in Research and Development:
In the field of chemical research and development, (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid serves as a valuable compound for studying its properties, reactivity, and potential applications in creating new materials or pharmaceuticals. Its complex structure and specific stereochemistry provide a foundation for exploring novel reactions and syntheses.
Used in Biochemical Studies:
(Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid is utilized as a subject of biochemical research to understand its interactions with biological molecules and its potential role in cellular processes. This knowledge can contribute to the development of targeted therapies and a deeper understanding of cellular mechanisms.
Used in Drug Delivery Systems:
As a component in drug delivery systems, (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid can be employed to improve the bioavailability and targeting of therapeutic agents. Its unique structure may allow for the development of novel drug carriers or enhance the efficacy of existing delivery methods.
Check Digit Verification of cas no
The CAS Registry Mumber 191919-02-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,9,1 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 191919-02:
(8*1)+(7*9)+(6*1)+(5*9)+(4*1)+(3*9)+(2*0)+(1*2)=155
155 % 10 = 5
So 191919-02-5 is a valid CAS Registry Number.
InChI:InChI=1/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,16-19,22-23H,2-3,5-6,8-14H2,1H3,(H,24,25)/b7-4-/t16-,17+,18-,19+/m0/s1
191919-02-5Relevant articles and documents
A PRACTICAL ROUTE FOR THE SYNTHESIS OF PROSTAGLANDIN D2 METABOLITES
Prakash, Chandra,Saleh, Samir,Taber, Douglass F.,Blair, Ian A.
, p. 245 - 256 (2007/10/02)
A convenient, efficient route for the total synthesis of 9α,11β-dihydroxy-13,14-dihydro-15-oxo-PGF2 2, a new plasma matabolite of prostaglandin D2 1 is described.
TOTAL SYNTHESIS OF 15-OXO-13,14-DIHYDRO-PROSTAGLANDIN F2α, A MAJOR METABOLITE OF PROSTAGLANDIN F2α
Marczak, S.,Wicha, J.
, p. 633 - 640 (2007/10/02)
The synthesis of prostaglandin F2α metabolite starting from Corey lactone is described.The key step of the synthesis involves chemoselective Wittig reaction.
